Trademark: INMAZEB
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for INMAZEB
We do not have any records of a proof of use for INMAZEB at this moment.
Possible trademark infringements of INMAZEB
Basic Information about INMAZEB
- Serial Number
- 88716277
- Filing Date
- 05 Dec 2019
- Registration Number
- 6503050
- Registration Date
- 28 Sep 2021
- Mark Drawing Code
- 4
Classifications
Declare the trademark use of INMAZEB on the blockchain with WikiTrademarks.io.
- First use of INMAZEB anywhere
- INMAZEB was first used on 28 Jul 2021 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns INMAZEB?
1. Regeneron Pharmaceuticals, Inc. Tarrytown NY
2. Regeneron Pharmaceuticals, Inc. Tarrytown NY
3. Regeneron Pharmaceuticals, Inc. Tarrytown NY
Correspondent
- Terrence J. McAllister
- OHLANDT, GREELEY, RUGGIERO & PERLE, LLP
- ONE LANDMARK SQUARE
- 10TH FLOOR
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io